Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

MDS Moves to Bigger Lab in Beijing

publication date: Oct 30, 2007
MDS Pharma Services, the CRO headquartered in Canada, moved its Beijing lab to a much larger facility. The new 25,000 square foot space affords five times the space for testing, four times the space for producing clinical trial kits, and a greater number of clinical trial testing services. In announcing the move, MDS noted that it was the first western CRO to own its testing facility in China. During the 10 years MDS has been operating in China, it has managed more than 30,000 patients in clinical trials. More details...

Stock Symbol: (NYSE: MDZ)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital